We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiotherapy Professionals Embrace AI as a Clinical Support Tool

By HospiMedica International staff writers
Posted on 18 Jul 2026

Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity. More...

Some clinicians also worry that artificial intelligence could erode skills or displace roles. A new study shows that AI contouring tools can streamline early planning steps while preserving expert oversight.

Researchers at King’s College London report that radiotherapy professionals across five regional cancer treatment centers in England were overwhelmingly positive about AI tools that generate first-draft contours of organs at risk (OAR) during treatment planning. The study was published in Sociology of Health & Illness. Clinicians used the software to propose organ boundaries and then reviewed and refined those outputs before finalizing plans.

The research assessed the lived experiences of 32 health care professionals, including clinical scientists, radiographers, dosimetrists, and oncologists. Participants described the technology as removing the most routine stage of delineation while keeping expert control of quality, safety, and accountability. Professionals emphasized that they retained responsibility for corrections and for the final treatment decision.

Interviewees reported that manual OAR drawing typically took between half an hour and two hours per patient, whereas AI produced a first draft in five to 10 minutes. They also noted that the systems could make basic mistakes, especially when anatomy or local practice diverged from training expectations, underscoring the continued need for human judgment. This “partial discard” of work helped explain why the tools were accepted so positively.

Clinicians said time saved by AI-supported contouring was redirected toward complex planning, service improvement, research, and more personalized patient care. The authors concluded that acceptance of AI in oncology depends on how well it fits specific tasks and workflows and whether it supports, rather than competes with, professional expertise.

“People worry about it replacing clinicians. I don't think our expertise is drawing around lumps and bumps,” said one oncologist.

“The research is timely as employers across health care and other professional sectors face growing pressure to introduce AI into complex, skilled work. Its central lesson is clear: AI may be more readily accepted when it is designed and implemented as a tool for experts, rather than an expert system that competes with them,” said Dr. Juan Baeza, reader in health policy at King’s Business School.

Related Links
King’s College London


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.